Skip to main content

7 Result(s)

within O. Klepp Remove this filter

and

  1. Article

    Open Access

    Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer

    The objective of this study was to assess markers of spermatogenesis in long-term survivors of testicular cancer (TC) according to treatment, and to explore correlations between the markers and associations wi...

    M Brydøy, S D Fosså, O Klepp, R M Bremnes, E A Wist, T Bjøro… in British Journal of Cancer (2012)

    Download PDF (346 KB) View Article

  2. No Access

    Article

    Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors

    We examined if testicular cancer (TC) treatment is associated with any risk for cardiovascular morbidity or predicted mortality according to the SCORE model, in which a 10-year future risk of ≥5% for developin...

    H. S. Haugnes, N. Aass, S. D. Fosså, O. Dahl, O. Klepp… in Journal of Cancer Survivorship (2008)

  3. No Access

    Article

    Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in Norway

    It is well documented that an increasing proportion of cancer patients today use complementary and alternative medicine, mostly alongside conventional therapies. This study investigates the use of complementar...

    A. Kolstad, T. Risberg, Y. Bremnes, T. Wilsgaard, H. Holte… in Supportive Care in Cancer (2004)

  4. No Access

    Article

    Neuron-specific enolase – a serum tumour marker in seminoma?

    The clinical significance of neuron-specific enolase (NSE) as a tumour marker was evaluated in 54 patients with seminoma. Before orchiectomy NSE was elevated in six out of 21 patients with stage I seminoma and...

    SD Fosså, O Klepp, E Paus in British Journal of Cancer (1992)

  5. No Access

    Chapter and Conference Paper

    Magnetic Resonance Imaging in Diagnosis and Follow-Up of Testis Cancer Patients: A Comparative Study

    Proper staging of the retroperitoneal area is a prerequisite for appropriate treatment of patients with all types and stages of testis cancer. Early detection of any retroperitoneal lymph node metastasis is im...

    O. Klepp, G. Myhr, O. Smevik, Å. Tangerud… in Tumor Response Monitoring and Treatment Pl… (1992)

  6. No Access

    Article

    Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer

    One-hundred and seventy patients with estrogen receptor positive (≥10 pmol/g protein) advanced breast cancer have been treated in a prospective randomized study either with continuous tamoxifen 30 mg × 1 daily...

    S. Gundersen, S. Kvinnsland, S. Lundgren, O. Klepp… in Breast Cancer Research and Treatment (1990)

  7. No Access

    Chapter

    Cyclical Use of Tamoxifen and High-Dose Medroxyprogesterone Acetate in Advanced Breast Cancer

    The response rate to endocrine therapy among unselected advanced breast cancer patients has remained constant around 30 percent since the first endocrine maneuver almost a century ago [1]. When patients are se...

    S. Gundersen, S. Kvinnsland, O. Klepp in Fundamental Problems in Breast Cancer (1987)